Right now, many Americans are being crushed by unaffordable out-of-pocket drug costs. Insurance isn’t working for many. And America is paying too much for older, branded drugs that should already be inexpensive generics.

Below, our easy-to-follow explainers diagnose today’s affordability problems, propose logical solutions, and innoculate against misguided reforms that would stunt innovation and raise healthcare costs in the long run.

Explore how making new medicines requires a partnership between the public and private sectors, why the US pays more for drugs than other countries, and why common cost-effectiveness methods underestimate a drug's value to society. These explainers have been viewed by patient advocates, economists, physicians, members of the drug and insurance industries, investors, and lawmakers, whose feedback we incorporated. We hope you, too, find them useful.